Financial Data and Key Metrics Changes - The same-store revenue growth for Q4 2025 was negative 0.1%, indicating stabilization compared to previous quarters [11] - Funds from Operations (FFO) per share for the quarter was reported at $0.64, with a 1.9% increase in the quarterly dividend to an annualized $2.12 per share, representing a 5.3% dividend yield [12] - The leverage ratio ended the year at 4.8x net debt to EBITDA, indicating a strong balance sheet [16] Business Line Data and Key Metrics Changes - The occupancy gap improved to 88.7% by the end of January 2026, narrowing from year-end 2025 [8] - Move-in rates showed significant improvement, turning positive at +2.8% in Q4 2025, compared to -10% in Q4 2024 [7] - Over 75% of the top 25 markets experienced revenue growth acceleration from Q3 to Q4 2025 [9] Market Data and Key Metrics Changes - Core urban markets in the Northeast and Midwest outperformed, while supply-impacted markets in the Sun Belt and West Coast began to show improvement [5][9] - Only 19% of same-store assets are projected to face new supply impacts in 2026, the lowest percentage since 2017 [10] Company Strategy and Development Direction - The company aims to return to growth in 2026, focusing on stabilizing fundamentals and improving operating metrics [5] - A new joint venture with CBRE IM was announced, with a $250 million mandate to invest in high-growth markets [13] - The company is considering share repurchases as a strategic option to enhance shareholder value amid disconnected public and private market valuations [15][48] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about returning to historical revenue growth levels, expecting gradual improvement throughout 2026 [9][39] - The company is focused on expense controls, having led the sector in the lowest expense growth over the past several years [18] - Management acknowledged the potential impact of economic conditions, including layoffs, on demand for self-storage services, but emphasized the resilience of the business model [56][99] Other Important Information - The company executed share repurchases during Q4 2025, with an expanded authorization allowing for approximately $475 million in capacity [15] - The company is exploring opportunities to sell or contribute assets to joint ventures to fund additional share repurchases if valuation gaps persist [16][70] Q&A Session Summary Question: How does the company view supply impacts? - The company assesses supply impacts over a three-year rolling period, with 19% of stores impacted in 2026, reflecting deliveries from 2024 to 2026 [21][23] Question: How is the company responding to the lawsuit in New York? - The company is monitoring the situation and remains focused on compliance and providing optimal customer experiences [25] Question: What is driving the higher operating expenses outlook? - Key drivers include real estate taxes and weather-related costs, with personnel costs expected to rise slightly above inflation [30] Question: What is the outlook for move-in rates? - Management expects steady improvement in move-in rates, with a focus on maximizing revenue from existing customers [36][62] Question: How does the company view its portfolio and potential dispositions? - The company is open to trading assets to enhance portfolio quality and may consider joint ventures for non-core assets [69][70]

花旗发布研报称，对康龙化成展开为期90天的正面催化观察，主要催化剂为公司即将公布2025年全年业 绩、订单增长加速公司今年的指引更乐观。报告指出，公司将成为客户需求复苏的领先指标，并为未来 收入增长提供更清晰指引，可能导致今财年指引高于市场共识，并推动股价正面重估。花旗对公司今年 每股盈利的预测较市场共识高出4%。 该行认为，公司是药物研发业务的全球领导者，正随着中国CRO行业的增长趋势发展；集团在维持药 物研发领导地位同时，亦正扩展至下游的后期临床开发和商业化生产，并涉足生物制剂领域。 智通财经APP获悉，康龙化成(03759)涨超3%，截至发稿，涨2.6%，报19.76港元，成交额1900.2万港 元。 ...

Financial Data and Key Metrics Changes - Fiscal 2025 non-GAAP diluted earnings per share for the legacy business was $3.74, a 22% increase from 2024 levels, marking the fourth consecutive year of double-digit earnings growth [11] - Total net sales for the year increased by 12% overall and 6% on an organic basis, with full-year adjusted operating margin expanding by 80 basis points to 9.4% [11][12] - The company expects a fifth year of double-digit non-GAAP EPS growth in 2026, with revenue growth anticipated to continue while driving bottom-line improvement [15][19] Business Line Data and Key Metrics Changes - In the legacy Workplace Furnishings business, full-year organic net sales increased by 6% year-over-year, with non-GAAP operating profit margin expanding by 100 basis points to 10.5% [12][13] - The Residential Building Products segment saw fourth-quarter revenue grow more than 10% compared to the same period in 2024, with full-year revenue increasing nearly 6% [13] - Segment non-GAAP operating profit margin in Residential Building Products expanded by 60 basis points year-over-year to 18.1% [13] Market Data and Key Metrics Changes - The company reported strong activity in the contract side of the business, with bid counts in the high teens, indicating healthy demand [28] - The macroeconomic picture for Workplace Furnishings is improving, with office leasing activity up more than 5% for the full year 2025 [19][20] - The new construction market remains weak, but the company expects continued outperformance in the remodel-retrofit segment [20][21] Company Strategy and Development Direction - The acquisition of Steelcase is expected to transform the company and the Workplace Furnishings industry, with anticipated synergies of $120 million and a focus on operational enhancements and digital transformation [8][9][21] - The company is committed to maintaining dealer partnerships and brand distribution, ensuring continuity for customers and dealers [10] - Investments are being made to drive top-line growth in Residential Building Products, focusing on customer engagement and go-to-market strategies [7][13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the demand dynamics for Workplace Furnishings, driven by a return to office trends and positive net absorption of office space [19][20] - The company acknowledges ongoing challenges in the new construction market but expects to outperform due to structural changes and growth investments [20][21] - Management remains optimistic about the integration of Steelcase and the potential for revenue synergies, although it is still early in the process [21][72] Other Important Information - The company ended the year with a net debt to EBITDA ratio of 2 times, with expectations for cash flow strength to continue and leverage to return to pre-deal levels in the next 18-24 months [17] - The company remains committed to its long-standing dividend while continuing to invest in business growth [18] Q&A Session Summary Question: Clarification on the outlook for the year regarding revenue and earnings growth - Management clarified that the double-digit growth for 2026 is based on the adjusted EPS of $3.53, excluding purchase accounting and the Steelcase stub period [25][26] Question: Confidence in the acceleration of Workplace Furnishings in the first quarter - Management noted strong bid counts and healthy activity in both legacy and Steelcase businesses, contributing to confidence in mid-single-digit growth for the full year [28][29] Question: Insights from the Steelcase acquisition - Management reported positive feedback from customers and dealers regarding the Steelcase integration, reinforcing confidence in the transaction [30][31] Question: Synergy expectations and potential upside - Management confirmed that the $120 million synergy target remains unchanged, with a focus on execution and potential for modest accretion in the first year [42][44] Question: Residential growth investments and margin expectations - Management indicated that margins in the Residential Building Products segment are expected to remain stable while pursuing growth investments [46][48] Question: Profit headwinds in the first quarter - Management explained that timing of revenue recognition and expenses related to the Steelcase acquisition are contributing to short-term pressure, but they expect double-digit EPS growth to accelerate in subsequent quarters [54][55] Question: Demand for design support and pipeline activity - Management acknowledged increased demand for design support and noted that many projects are in the pipeline but not yet in the order backlog, with efforts underway to facilitate conversions [61][63]

Financial Data and Key Metrics Changes - BGC delivered record-breaking revenues for both the fourth quarter and full year 2025, with increases of 32% and 30% respectively, approaching $3 billion in revenues [4] - Adjusted EPS grew by 24% under GAAP and 19% for adjusted earnings [4] - Pre-tax adjusted earnings grew by 24.5% to $161.3 million, representing a pre-tax margin of 21.3% [18] - Post-tax adjusted earnings increased by 21.1% to $149.6 million, resulting in a post-tax adjusted earnings per share of $0.31 [18] Business Line Data and Key Metrics Changes - Total brokerage revenues grew by 34.6% to $694.6 million, driven by growth across all asset classes [9] - ECS revenues grew by 92% to $257.5 million, with strong organic growth across the broader energy complex and shipping business [9] - Rates revenues increased by 16.4% to $197.4 million, reflecting strong growth in G-10 interest rate products [10] - Foreign exchange revenues were up 9.8% to $102.8 million, primarily due to strong growth in emerging market currencies [10] - Fenics revenues increased by 15.4% to a fourth quarter record of $163.9 million [11] Market Data and Key Metrics Changes - EMEA revenue increased by 39.2%, Americas revenues increased by 25.7%, and Asia Pacific revenues increased by 24.2% [16] - FMX UST business ended 2025 with a 40% market share, with average daily volume increasing by 12% compared to last year [12] - FMX Futures Exchange saw record volumes in open interest, with ADV and open interest increasing 82% and 97% respectively [12] Company Strategy and Development Direction - The company completed the first phase of its cost reduction program, realizing $25 million of annualized savings in 2026 [5] - BGC aims to focus on higher growth areas within its portfolio, having sold lower growth businesses to enhance shareholder value [28] - The company is positioned for continued success as it moves into 2026, with a record-breaking start to the year [7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory, with guidance for first quarter 2026 revenues expected to be between $860 million and $920 million, representing approximately 34% revenue growth [20] - The company anticipates pre-tax adjusted earnings to be in the range of $202 million to $222 million, indicating over 32% earnings growth [20] - Management noted that the trading environment remains strong, contributing to organic revenue growth [25] Other Important Information - The company achieved the strongest annual results in its history, significantly expanding its market share and becoming the world's largest energy broker [4] - The liquidity as of December 31 was $979.1 million, compared to $897.8 million at year-end 2024 [19] Q&A Session Summary Question: About the first quarter guidance and organic revenue growth - Management indicated that the strong growth is driven by a combination of a favorable trading environment and sustainable growth drivers across the business [25] Question: Thoughts on the sale of KACE and future divestitures - Management stated that the sale was driven by a focus on shareholder value and that they remain open to future divestitures if they do not align with growth objectives [28] Question: New logo growth in the energy space - Management confirmed that there is a proliferation of new players in the ECS business, benefiting from the current market environment [34] Question: Market share of ECS exceeding combined market share of BGC and OTC - Management confirmed that the benefits of acquiring OTC have become evident, with strong positioning in key asset classes [36] Question: Timetable for recognizing revenue related to FMX futures - Management indicated that changes in fee structures will occur in the summer, and the launch of Treasury futures will follow the success of SOFR [42][43] Question: Additional fixed income products within Lucera - Management mentioned that Lucera is moving into credit markets, which could represent a significant portion of future revenue if successful [49]

Financial Data and Key Metrics Changes - IRadimed achieved record revenue for the 18th consecutive quarter, with Q4 2025 revenue reaching $22.7 million, a 17% increase from Q4 2024, and full-year revenue of $83.8 million, up 14% year-over-year [3][10] - GAAP diluted earnings per share for Q4 was $0.50, up 25%, and for the full year, it reached $1.75, up 17% [3][12] - Gross margins remained strong at approximately 77% for the year and 75% for Q4 [3][11] Business Line Data and Key Metrics Changes - MRI-compatible infusion pump systems contributed $9.1 million in Q4, up 20% year-over-year, while patient vital signs monitoring systems contributed $7.1 million, up 7.5% [10] - Disposable revenue grew 18% to $4.3 million, reflecting increased utilization of devices [10][11] Market Data and Key Metrics Changes - Domestic sales accounted for 81% of total revenue in Q4 and 84% for the full year, indicating strong U.S. performance [11] - There are approximately 6,400 5+-year-old 3860/3861 pump channels in the U.S. market that are up for replacement [6] Company Strategy and Development Direction - The company anticipates a significant increase in revenue from the replacement of older pump models, which is expected to be a key growth driver for the next several years [5][7] - The new 3870 MR IV pump is expected to penetrate greenfield opportunities more effectively and increase utilization among existing customers [4][5] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a $100 million-plus revenue run rate during 2026, driven by the new 3870 pump and increased disposable sales [7][8] - The company plans to maintain quarterly revenue in the first half of 2026, with significant growth expected in the second half [8] Other Important Information - The company ended the year with cash and cash equivalents of $51.2 million, and cash flow from operations was $5.9 million for Q4 and $24.9 million for the full year [12] - The company is working on a next-generation MRI monitor expected to launch in 2028 [21] Q&A Session Summary Question: Initial market feedback from the pilot - Management reported very positive feedback from initial users of the 3870 pump, leading to confidence in scaling the launch [15][16] Question: Gross margin scaling - Management indicated that gross margins are expected to remain stable in the first half of the year but may improve in the second half due to higher volumes and ASP [18][19] Question: Updates on disposables and services growth - Management noted that disposable revenue growth is expected to align with capital sales, with potential for increased utilization with the new 3870 pump [26][27] Question: Inventory levels and backlog for the 3860 - Management stated that inventory levels are being closely monitored to ensure fulfillment of backlog while transitioning to the 3870 [28][29] Question: Regulatory process for 3870 in Europe and Japan - Management confirmed that CE mark approval is expected by the end of 2026, with Japan clearance anticipated by summer 2027 [32]

Core Viewpoint - Peijia Medical expects revenue in 2025 to be approximately 7.0 to 7.2 billion yuan, representing a year-on-year growth of about 13.7% to 17.0% driven by strong performance across all three product lines in the neurointervention business and an expanding market share in the transcatheter aortic valve replacement (TAVR) sector, primarily due to the successful launch of the high-end TaurusMax 3D adjustable TAVR system [1] Group 1 - The expected revenue for 2025 is projected to be around 7.0 to 7.2 billion yuan [1] - The year-on-year growth rate is estimated to be between 13.7% and 17.0% [1] - The growth is attributed to strong performance in all three product lines of the neurointervention business [1] Group 2 - The market share in the TAVR sector is continuously expanding [1] - The expansion is mainly driven by the successful launch of the TaurusMax 3D adjustable TAVR system [1]

Core Viewpoint - New Oriental-S (09901) reported strong financial results for the second quarter of fiscal year 2026, with significant year-on-year growth in revenue and profit metrics, leading to a stock price increase of over 4% [1] Financial Performance - For the second quarter of fiscal year 2026, net revenue increased by 14.7% year-on-year to $1.191 billion [1] - Operating profit surged by 244.4% year-on-year to $66.3 million [1] - Net profit attributable to shareholders rose by 42.3% year-on-year to $45.5 million [1] - For the first half of fiscal year 2026, net revenue was approximately $2.714 billion, reflecting a year-on-year growth of 9.7% [1] - Operating profit for the first half was about $377 million, up 20.7% year-on-year [1] - Net profit attributable to shareholders for the first half was approximately $286 million, a year-on-year increase of 3.2% [1] Market Expectations - Bank of America Securities noted that New Oriental-S's revenue and profit margins exceeded expectations for the second fiscal quarter [1] - Revenue growth accelerated to 15%, surpassing the guidance of 9% to 12% [1] - Non-GAAP operating profit margin expanded by 4.8 percentage points, also exceeding the guidance of "over 1 percentage point" [1] - The company provided a revenue growth guidance of 11% to 14% for the third fiscal quarter ending in February [1] - Full fiscal year revenue guidance was raised to $5.3 billion to $5.5 billion, indicating a year-on-year growth of 8% to 12%, up from the previous guidance of 5% to 10% [1] - The primary growth drivers include K12 business, Dongfang Zhenxuan, and a narrowing decline in overseas exam preparation services [1]

Financial Data and Key Metrics Changes - The company reported a 1% increase in volume, but revenue decreased by 1% due to business mix headwinds and coal pricing [9][14] - Operating income and earnings per share fell by 9% and 7% year-over-year, respectively, with results impacted by approximately $50 million in charges for workforce optimization and technology impairments [4][10] - Fourth quarter expenses increased by $73 million, or 3%, excluding goodwill impairment charges [10] Business Line Data and Key Metrics Changes - Merchandise volume and revenue both declined by 2%, with softness in chemicals and forest products, where volume decreased by 6% and 11%, respectively [15] - The intermodal franchise saw a revenue increase of 7% year-over-year, driven by a 5% increase in volume [16] - Coal business volume increased by 1% year-over-year, with domestic tonnage up by 6% due to higher utility demand [16][17] Market Data and Key Metrics Changes - The company anticipates modest declines in housing starts and challenges in the automotive market, affecting many commodity markets [18] - The consensus forecasts suggest low single-digit revenue growth for 2026, with flat industrial production and modest GDP growth expected [22] - The company is positioned to benefit from infrastructure project activity driving demand for materials like cement and aggregates [17] Company Strategy and Development Direction - The company is focused on driving greater profitability and cash flow while preparing for future demand increases [6] - Capital expenditures for 2026 are planned to be below $2.4 billion, emphasizing investments in safety, reliability, and growth projects [23] - The company is committed to optimizing its workforce and managing discretionary expenses to improve operating margins [22][24] Management's Comments on Operating Environment and Future Outlook - Management noted that the near-term outlook remains soft across many key markets, with no significant improvement in macroeconomic conditions anticipated [22] - The company is focused on executing core fundamentals of service, cost discipline, and operating efficiency to create long-term shareholder value [24] - Management expressed confidence in the ability to improve operating margins through productivity initiatives and effective price management [38][68] Other Important Information - The company has identified over 100 diverse savings initiatives to drive efficiency across various business areas [11][52] - The leadership team has been renewed to enhance value creation and fiscal responsibility [5] - The company is preparing for potential impacts from severe weather, with improved network conditions compared to previous years [42][43] Q&A Session All Questions and Answers Question: Inquiry on Operating Ratio Improvement - The base operating ratio for 2025 is adjusted for goodwill charges, and pricing initiatives are expected to yield higher price yields in 2026 compared to 2025 [27][28] Question: Clarification on Guidance for Improvement - The guidance for 200-300 basis points improvement includes unique charges from 2025, with a focus on productivity initiatives to drive further improvements [32][33] Question: Revenue Growth Composition - The company anticipates low single-digit revenue growth, with modest volume growth expected and a focus on pricing management [36][37] Question: Preparation for Severe Weather - The network is in better condition than last year, with precautions in place to mitigate impacts from upcoming storms [42][43] Question: Positioning Amid Industry Merger - The company is focused on running its business effectively while preparing for potential opportunities arising from industry changes [55][56] Question: Coal Revenue Per Unit Clarification - Revenue per unit for coal is influenced by market mix, with expectations for stabilization in the coming year [60][63]

Group 1 - The core viewpoint of the report is that the company maintains a "Hold" rating for China Resources Mixc Lifestyle Services (01209), with the target price raised from HKD 41.1 to HKD 43 [1] - The company is projected to achieve a 12.2% year-on-year growth in core net profit for 2025, with revenue expected to increase by 6.8% [1] - The property management business revenue is anticipated to be significantly impacted by a sharp decline in value-added services, with a modest growth of only 1.4% expected [1] Group 2 - The commercial operations revenue is estimated to grow by 16.8% driven by the increase in shopping center revenue [1] - Due to the ongoing pressure on value-added services, the company's profit forecasts for 2025 to 2027 have been revised downwards by 3.4%, 6.4%, and 7.2% respectively [1]

Core Viewpoint - Vaccine manufacturer Moderna expects sales of approximately $1.9 billion for the previous year, nearing the upper limit of its prior forecast of $1.6 billion to $2 billion, but significantly lower than revenue levels during the pandemic [1] Financial Performance - The company has reduced its 2025 operating expense forecast by $200 million, adjusting the range to $5 billion to $5.2 billion [1] - Moderna anticipates an ending cash balance of $8.1 billion, exceeding the previous forecast of $6.5 billion to $7 billion [1] Future Outlook - The company reaffirms its goal of achieving revenue growth of up to 10% this year [1] - Moderna expects to receive regulatory approval for an independent flu vaccine and a combined flu vaccine this year [1]